<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for Enzon Pharmaceuticals Inc - Google Finance</title>
<description>News for Enzon Pharmaceuticals Inc - Google Finance</description>
<link>http://www.google.com/finance?q=NASDAQ:ENZN&amp;amp;client=news-rss&amp;amp;ei=nTueUYjKHuWu0AGvPw</link>
<image>
<title>News for Enzon Pharmaceuticals Inc - Google Finance</title>
<url>/finance/s/M4XFgDr56u4/images/logo_us.gif</url>
<link>http://www.google.com/finance?q=NASDAQ:ENZN&amp;amp;client=news-rss&amp;amp;ei=nTueUYjKHuWu0AGvPw</link>
</image>
<item>
<title>Tranzyme, Inc. (NASDAQ:TZYM), Enzon Pharmaceuticals Inc. (NASDAQ:ENZN ...</title>
<link>http://www.sbwire.com/press-releases/tranzyme-inc-nasdaqtzym-enzon-pharmaceuticals-inc-nasdaqenzn-and-amgen-inc-nasdaqamgn-added-to-equity-profile-reports-nasdaq-decliners-watch-list-242251.htm</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778127312577</guid>
<pubDate>Wed, 24 Apr 2013 19:32:51 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.sbwire.com/press-releases/tranzyme-inc-nasdaqtzym-enzon-pharmaceuticals-inc-nasdaqenzn-and-amgen-inc-nasdaqamgn-added-to-equity-profile-reports-nasdaq-decliners-watch-list-242251.htm&quot; style=&quot;font-size:1.2em&quot;&gt;Tranzyme, Inc. (NASDAQ:TZYM), Enzon Pharmaceuticals Inc. (NASDAQ:ENZN ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;SBWire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 24, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Wilmington, DE -- (SBWIRE) -- 04/24/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Tranzyme, Inc. (NASDAQ:TZYM), Enzon Pharmaceuticals Inc. (NASDAQ:ENZN), and Amgen Inc. (NASDAQ:AMGN). Tranzyme, Inc.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>ENZON PHARMACEUTICALS INC : Enzon Concludes Review of Possible Asset ...</title>
<link>http://www.4-traders.com/ENZON-PHARMACEUTICALS-INC-9188/news/Enzon-Pharmaceuticals-Inc-Enzon-Concludes-Review-of-Possible-Asset-Sales-Sale-of-the-Company-Ann-16770121/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778129703057</guid>
<pubDate>Tue, 23 Apr 2013 21:03:51 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/ENZON-PHARMACEUTICALS-INC-9188/news/Enzon-Pharmaceuticals-Inc-Enzon-Concludes-Review-of-Possible-Asset-Sales-Sale-of-the-Company-Ann-16770121/&quot; style=&quot;font-size:1.2em&quot;&gt;ENZON PHARMACEUTICALS INC : Enzon Concludes Review of Possible Asset ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 23, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;PISCATAWAY, NJ -- (Marketwired) -- 04/23/13 -- Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) today announced that it has concluded a thorough review of the possible sale or disposition of one or more corporate assets, or a sale of the Company, and that ...&lt;/div&gt;
&lt;a href=&quot;http://online.wsj.com/article/BT-CO-20130423-716430.html?mod=googlenews_wsj&quot;&gt;Enzon Unveils Special Dividend, Concludes Strategic Review&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Wall Street Journal&lt;/span&gt;&lt;br&gt;
&lt;a href=&quot;http://www.mideasttime.com/enzon-pharmaceuticals-enzn-declares-special-dividend-of-1-60/12578/&quot;&gt;Enzon Pharmaceuticals (ENZN) Declares Special Dividend of $1.60&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Mideast Time&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>What&amp;#39;s Next: iRobot, Enzon Pharmaceuticals, Yum, Broadcom</title>
<link>http://www.sbwire.com/press-releases/whats-next-irobot-enzon-pharmaceuticals-yum-broadcom-242141.htm</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778130708440</guid>
<pubDate>Wed, 24 Apr 2013 16:26:24 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.sbwire.com/press-releases/whats-next-irobot-enzon-pharmaceuticals-yum-broadcom-242141.htm&quot; style=&quot;font-size:1.2em&quot;&gt;What&amp;#39;s Next: iRobot, Enzon Pharmaceuticals, Yum, Broadcom&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;SBWire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 24, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) declined 11.20% to $3.40 on a traded volume of 191k shares. Enzon Pharmaceuticals, Inc. has concluded a thorough review of the possible sale or disposition of one or more corporate assets, or a sale of the ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>TOP 10 GAINERS (After-Hours) Today – iRobot Corporation, OCZ Technology ...</title>
<link>http://www.pentagonpost.com/top-10-gainers-after-hours-today-irobot-corporation-ocz-technology-enzon-pharmaceuticals-apple-inc-irbt-ocz-aapl-enzn-velt-flir-wlt-imrs-ogen-brcm/8346834</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778129991926</guid>
<pubDate>Wed, 24 Apr 2013 11:46:04 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.pentagonpost.com/top-10-gainers-after-hours-today-irobot-corporation-ocz-technology-enzon-pharmaceuticals-apple-inc-irbt-ocz-aapl-enzn-velt-flir-wlt-imrs-ogen-brcm/8346834&quot; style=&quot;font-size:1.2em&quot;&gt;TOP 10 GAINERS (After-Hours) Today – iRobot Corporation, OCZ Technology ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Pentagon Post&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 24, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Enzon Pharmaceuticals Inc. (NASDAQ: ENZN) traded at $4.05, up 5.7 percent during After-Hours on 2,400 share volume. The company traded -7.50 percent below its 50-day moving average and -16.84 percent below its 200-day moving average.&lt;/div&gt;
&lt;a href=&quot;http://fxpips.com/after-hours-top-10-gainers-today-irobot-corp-ocz-tech-enzon-pharma-velti-plc-apple-inc-irbt-ocz-enzn-aapl-velt-imrs-flir-wlt-ogen-brcm/&quot;&gt;AFTER-HOURS Top 10 Gainers Today – iRobot Corp, OCZ Tech, Enzon ...&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;FxPips.com (blog)&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Investors Buzz: Enzon Pharmaceuticals Inc (NASDAQ:ENZN), The Procter ...</title>
<link>http://www.meshpress.com/investors-buzz-enzon-pharmaceuticals-inc-nasdaqenzn-the-procter-gamble-companynysepg-celgene-corporation-nasdaqcelg/1235700.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778131843400</guid>
<pubDate>Thu, 25 Apr 2013 12:23:02 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.meshpress.com/investors-buzz-enzon-pharmaceuticals-inc-nasdaqenzn-the-procter-gamble-companynysepg-celgene-corporation-nasdaqcelg/1235700.html&quot; style=&quot;font-size:1.2em&quot;&gt;Investors Buzz: Enzon Pharmaceuticals Inc (NASDAQ:ENZN), The Procter ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Mesh Press (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 25, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Enzon Pharmaceuticals Inc (NASDAQ:ENZN) shares dropped 11.23% to $3.40. The company on April 23 announced that it has concluded a thorough review of the possible sale or disposition of one or more corporate assets, or a sale of the Company, and ...&lt;/div&gt;
&lt;a href=&quot;http://www.techsonian.com/micro-cap-top-losers-vocus-inc-enzon-pharmaceuticals-inc-hawaiian-holdings-inc-cytokinetics-inc/121443/&quot;&gt;Micro Cap Top Losers: Vocus, Inc., Enzon Pharmaceuticals Inc, Hawaiian ...&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Techsonian (press release)&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Alex Denner Joins Vivus Activist Slate in First Post-Icahn Move</title>
<link>http://www.businessweek.com/news/2013-05-23/alex-denner-joins-vivus-activist-slate-in-first-post-icahn-move</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982070507915</guid>
<pubDate>Thu, 23 May 2013 14:02:52 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.businessweek.com/news/2013-05-23/alex-denner-joins-vivus-activist-slate-in-first-post-icahn-move&quot; style=&quot;font-size:1.2em&quot;&gt;Alex Denner Joins Vivus Activist Slate in First Post-Icahn Move&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Businessweek&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;1 hour ago &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;... leading Icahn&amp;#39;s forays into biotechnology companies, is a director at Biogen Idec Inc. (BIIB) and Enzon Pharmaceuticals Inc. (ENZN) He also has served on the boards of ImClone Systems Inc., Amylin Pharmaceuticals Inc. and Adventrx Pharmaceuticals Inc.&lt;/div&gt;
&lt;a href=&quot;http://www.4-traders.com/BIOGEN-IDEC-INC-4853/news/Dissident-Holder-First-Manhattan-Adds-3-to-Vivus-Board-Slate-16904413/&quot;&gt;Dissident Holder First Manhattan Adds 3 to Vivus Board Slate&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;4-traders (press release)&lt;/span&gt;&lt;br&gt;
&lt;a href=&quot;http://www.fortmilltimes.com/2013/05/23/2710563/first-manhattan-adds-alex-denner.html&quot;&gt;First Manhattan Adds Alex Denner to Vivus Board Slate&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Fort Mills Times&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Baupost Buys Elan Corp, DIRECTV, Sells Genworth, News Corp</title>
<link>http://www.valuewalk.com/2013/05/baupost-buys-elan-corp-directv-sells-genworth-news-corp/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982061690897</guid>
<pubDate>Wed, 15 May 2013 15:02:22 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.valuewalk.com/2013/05/baupost-buys-elan-corp-directv-sells-genworth-news-corp/&quot; style=&quot;font-size:1.2em&quot;&gt;Baupost Buys Elan Corp, DIRECTV, Sells Genworth, News Corp&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;ValueWalk&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 15, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;During the period, Baupost reduced its stockholdings in the following companies: Enzon Pharmaceuticals Inc (NASDAQ:ENZN) by 158,918 shares, Alliance One international Inc (NYSE:AOI) by 655,106 shares, Ituran Location &amp;amp; Control Ltd (NASDAQ:ITRN) ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Carl Icahn&amp;#39;s Q1 13F Reveals Little New</title>
<link>http://www.streetinsider.com/13Fs/Carl+Icahns+Q1+13F+Reveals+Little+New/8344690.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.streetinsider.com/13Fs/Carl+Icahns+Q1+13F+Reveals+Little+New/8344690.html</guid>
<pubDate>Wed, 15 May 2013 21:49:41 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.streetinsider.com/13Fs/Carl+Icahns+Q1+13F+Reveals+Little+New/8344690.html&quot; style=&quot;font-size:1.2em&quot;&gt;Carl Icahn&amp;#39;s Q1 13F Reveals Little New&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;StreetInsider.com (subscription)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 15, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) maintained 5,904,863 share stake. Federal-Mogul Corporation (NASDAQ: FDML) maintained 76,697,804 share stake.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Top Gainers in After-hours Today, April 23</title>
<link>http://marketsntrade.com/smw/43867/Top-Gainers-in-After-hours-Today-April-23</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778128285259</guid>
<pubDate>Tue, 23 Apr 2013 21:17:06 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://marketsntrade.com/smw/43867/Top-Gainers-in-After-hours-Today-April-23&quot; style=&quot;font-size:1.2em&quot;&gt;Top Gainers in After-hours Today, April 23&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;MarketsNTrade&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 23, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Enzon Pharmaceuticals, Inc. is engaged in developing, manufacturing and commercializing important medicines for patients with cancer and other life-threatening conditions.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Micro-Cap Stocks Volatile on News: Vocus (VOCS), Superconductor (SCON ...</title>
<link>http://www.therem.org/micro-cap-stocks-volatile-on-news-vocus-vocs-superconductor-scon-enzon-enzn-cytokinetics-cytk-delcath-systems-dcth/123376/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.therem.org/micro-cap-stocks-volatile-on-news-vocus-vocs-superconductor-scon-enzon-enzn-cytokinetics-cytk-delcath-systems-dcth/123376/</guid>
<pubDate>Thu, 25 Apr 2013 12:38:15 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.therem.org/micro-cap-stocks-volatile-on-news-vocus-vocs-superconductor-scon-enzon-enzn-cytokinetics-cytk-delcath-systems-dcth/123376/&quot; style=&quot;font-size:1.2em&quot;&gt;Micro-Cap Stocks Volatile on News: Vocus (VOCS), Superconductor (SCON ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;REM&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 25, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Enzon Pharmaceuticals Inc(NASDAQ:ENZN) finished last trading day, -11.23% lower to move at $3.40 after concluded review of possible asset sale, sale of company and declared special dividend of $1.60 per share.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
